BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 28914368)

  • 1. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
    Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
    Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
    PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
    Triggianese P; Vitale A; Lopalco G; Mayrink Giardini HA; Ciccia F; Al-Maghlouth I; Ruscitti P; Sfikakis PP; Iannone F; de Brito Antonelli IP; Patrone M; Asfina KN; Di Cola I; Laskari K; Gaggiano C; Tufan A; Sfriso P; Dagna L; Giacomelli R; Hinojosa-Azaola A; Ragab G; Fotis L; Direskeneli H; Spedicato V; Dagostin MA; Iacono D; Ali HH; Cipriani P; Sota J; Kardas RC; Bindoli S; Campochiaro C; Navarini L; Gentileschi S; Martín-Nares E; Torres-Ruiz J; Saad MA; Kourtesi K; Alibaz-Oner F; Sevik G; Iagnocco A; Makowska J; Govoni M; Monti S; Maggio MC; La Torre F; Del Giudice E; Hernández-Rodríguez J; Bartoloni E; Emmi G; Chimenti MS; Maier A; Simonini G; Conti G; Olivieri AN; Tarsia M; De Paulis A; Lo Gullo A; Więsik-Szewczyk E; Viapiana O; Ogunjimi B; Tharwat S; Erten S; Nuzzolese R; Karamanakos A; Frassi M; Conforti A; Caggiano V; Marino A; Sebastiani GD; Gidaro A; Tombetti E; Carubbi F; Rubegni G; Cartocci A; Balistreri A; Fabiani C; Frediani B; Cantarini L
    Intern Emerg Med; 2023 Nov; 18(8):2231-2243. PubMed ID: 37828268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.
    Gorelik M; Torok KS; Kietz DA; Hirsch R
    J Rheumatol; 2011 Feb; 38(2):396-7. PubMed ID: 21285182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
    Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease.
    Uppal SS; Pande IR; Kumar A; Kailash S; Sekharan NG; Adya CM; Malaviya AN
    Br J Rheumatol; 1995 May; 34(5):429-34. PubMed ID: 7788171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and evolving concepts in Still's disease.
    Ruscitti P; Cantarini L; Nigrovic PA; McGonagle D; Giacomelli R
    Nat Rev Rheumatol; 2024 Feb; 20(2):116-132. PubMed ID: 38212542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.
    Ruscitti P; Cipriani P; Masedu F; Iacono D; Ciccia F; Liakouli V; Guggino G; Carubbi F; Berardicurti O; Di Benedetto P; Valenti M; Triolo G; Valentini G; Giacomelli R
    BMC Med; 2016 Dec; 14(1):194. PubMed ID: 27903264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
    Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
    Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
    Gulzar M; Sabir A; Hamdani MA; Saadia A
    J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
    Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
    Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
    Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
    Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.